Guido Marcucci MD

Guido Marcucci, M.D., thinks of acute myeloid leukemia (AML) as the “prototype of cancer and how cancer develops,” which makes it a prime target for intensive research, and the focus of much of Dr. Marcucci's distinguished career. Dr. Marcucci joined City of Hope in 2014 from Ohio State University, where he was a professor of internal medicine, molecular virology, immunology, medical genetics and pharmaceutics in the division of hematology at the university’s comprehensive cancer center.

At City of Hope, Dr. Marcucci is playing a key role in our efforts to further expand and broaden our world-renowned work in leukemia research and treatment. He directs the Gehr Family Center for Leukemia Research and serves as chair of the Department of Hematologic Malignancies Translational Science. A nationally-recognized authority on leukemia, Dr. Marcucci has lectured around the world and authored more than 270 scholarly papers on the subject. His ultimate goal is to make leukemia a thing of the past. He has received numerous competitive NCI grants for his clinical and research work focused on the pathogenesis, treatment and prognostic assessment of patients with acute myeloid leukemia. Dr. Marcucci currently serves on the editorial board of three journals, including Blood and the Journal of Clinical Oncology.